Press Releases Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-09 EDT			5-day change	1st Jan Change
1.66 ^USD	+22.96%		+16.90%	-36.64%

05-09	Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical	CI
05-09	Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q1 Revenue $10.2M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apyx: Q1 Earnings Snapshot	05-09	AQ
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook	05-09	BU
Apyx Medical Corporation Announces Board Leadership Transition	05-09	BU
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	04-25	BU
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT	04-12	AQ
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit	04-11	BU
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK	03-22	AQ
Apyx: Q4 Earnings Snapshot	03-21	AQ
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook	03-21	BU
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024	03-04	BU
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING	02-22	AQ
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting	02-21	BU
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY	01-23	AQ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	01-22	BU
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results	01-08	BU
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer	11-28	BU
Apyx: Q3 Earnings Snapshot	11-09	AQ
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors	11-09	BU
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook	11-09	BU
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November	11-07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Apyx Medical Corporation

Equities

APYX

US03837C1062

Press Releases

Filters